Lars Jørgen Østergaard

  1. Journal article › Research › Peer-reviewed
  2. Published

    A comparison of sexual behaviour and attitudes of healthy adolescents in a Danish high school in 1982, 1996, and 2001. / Kangas, Ida; Andersen, Berit; McGarrigle, Christine; ØStergaard, Lars.

    In: Population Health Metrics, Vol. 2, No. 1, 2004, p. 5.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  3. Published

    A comparison of the long-term durability of nevirapine, efavirenz and lopinavir in routine clinical practice in Europe : a EuroSIDA study. / Reekie, J; Reiss, P; Ledergerber, B; Sedlacek, D; Parczewski, M; Gatell, J; Katlama, C; Fätkenheuer, G; Lundgren, J D; Mocroft, A; EuroSIDA study group (Lars Østergaard, member).

    In: HIV Medicine, Vol. 12, No. 5, 05.2011, p. 259-68.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  4. Published

    A novel toll-like receptor-9 agonist, MGN1703, enhances HIV-1 transcription and NK cell-mediated inhibition of HIV-1 infected autologous CD4+ T cells. / Offersen, Rasmus; Nissen, Sara Konstantin; Rasmussen, Thomas Aagaard; Østergaard, Lars Jørgen; Denton, Paul W; Søgaard, Ole Schmeltz; Tolstrup, Martin.

    In: Journal of Virology, 17.02.2016.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  5. Published

    A phase 3, randomized, active-controlled study to assess the safety and tolerability of meningococcal serogroup B vaccine bivalent rLP2086 in healthy adolescents and young adults. / Østergaard, Lars Jørgen; Lucksinger, Gregg H; Absalon, Judith; Beeslaar, Johannes; Eiden, Joseph; Jansen, Kathrin U; York, Laura J; Quinn, Angela; Graversen, Mette E; Perez, John L.

    In: Vaccine, 01.02.2016.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  6. Published

    A review of macrolide treatment of atherosclerosis and abdominal aortic aneurysms. / Lindholt, Jes S; Stovring, Jette; Andersen, Paul Lehm; Henneberg, Eskild W; Østergaard, Lars.

    In: Infectious Disorders - Drug Targets, Vol. 3, No. 1, 2003, p. 55-63.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  7. Published

    A standardized algorithm for determining the underlying cause of death in HIV infection as AIDS or non-AIDS related : results from the EuroSIDA study. / Kowalska, Justyna D; Mocroft, Amanda; Ledergerber, Bruno; Florence, Eric; Ristola, Matti; Begovac, Josip; Sambatakou, Helen; Pedersen, Court; Lundgren, Jens D; Kirk, Ole; Eurosida Study Group (Lars Østergaard, member).

    In: HIV Clinical Trials, Vol. 12, No. 2, 19.04.2011, p. 109-17.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  8. Published

    A survey of ATRIPLA use in clinical practice as first-line therapy in HIV-positive persons in Europe. / for EuroSIDA in EuroCOORD.

    In: Infection, Vol. 42, No. 4, 01.08.2014, p. 757-762.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  9. Published

    A tetravalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine is immunogenic and well-tolerated when co-administered with Twinrix(®) in subjects aged 11-17 years: An open, randomised, controlled trial. / Østergaard, Lars Jørgen; Silfverdal, S A; Berglund, J; Flodmark, C E; West, C; Bianco, V; Baine, Y; Miller, J.

    In: Vaccine Weekly, 2011.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  10. Published

    A376S in the connection subdomain of HIV-1 reverse transcriptase confers increased risk of virological failure to nevirapine therapy. / Paredes, Roger; Puertas, Maria Carmen; Bannister, Wendy; Kisic, Mónica; Cozzi-Lepri, Alessandro; Pou, Christian; Bellido, Rocío; Betancor, Gilberto; Bogner, Johannes; Gargalianos, Panagiotis; Bánhegyi, Dénes; Clotet, Bonaventura; Lundgren, Jens; Menéndez-Arias, Luis; Martinez-Picado, Javier; EuroSIDA Study Group (Lars Østergaard, member).

    In: Journal of Infectious Diseases, Vol. 204, No. 5, 01.09.2011, p. 741-52.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  11. Published

    ART influences HIV persistence in the female reproductive tract and cervicovaginal secretions. / Olesen, Rikke; Swanson, Michael D; Kovarova, Martina; Nochi, Tomonori; Chateau, Morgan; Honeycutt, Jenna B; Long, Julie M; Denton, Paul W; Hudgens, Michael G; Richardson, Amy; Tolstrup, Martin; Østergaard, Lars Jørgen; Wahl, Angela; Garcia, J Victor.

    In: Journal of Clinical Investigation, 08.02.2016.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

Previous 1 2 3 4 5 6 7 8 ...39 Next